[ABSTRACT] AIM: To study the chemical constituents of the whole plants of E. chinensis, and find new or effective components. METHODS: Compounds were isolated by repeated silica gel and Sephadex LH-20 column chromatography. The structures were elucidated by NMR and HRESI-MS spectrometry. RESULTS: Six alkaloids were isolated from whole plants of E. chinensis, and their structures were elucidated as ervachinine E (1), rutaecarpine (2), 1-methyl-2-nonyl-4(1H)-quinolone (3), dihydroevocarpine (4), evocarpine (5), and 1-methyl-2-[(Z)-6-undecenyl]-4(1H)-quinolone (6), respectively. CONCLUSION: Compound 1 is a new monoterpenoid indole alkaloid and with moderate anti-tumor activity, while compounds 2-6 are reported from this species for the first time. 
Introduction
Monoterpenoid indole alkaloids are structurally diversified alkaloids elaborated by the plant of the Apocynaceae family [1] . Some of these alkaloids, such as vinblastine, reserpine, and ibogamine, have important pharmaceutical applications [2] [3] . The genus Ervatamia (Apocynaceae family) has fifteen plant species and five varieties growing in the south of China [2] , and many of them have been applied as traditional Chinese medicines for the treatment of hypertension and sore throat [4] . Previous chemical investigation on this genus reported the isolation of more than 300 indole alkaloids, some of which showed excellent antitumor activities [5] . A preliminary study on Ervatamia chinensis led to the isolation of five vobasinyl-ibogan type bisindole alkaloids and 11 terpenoid indole alkaloids [6] . As a part of our phytochemical investigation on plants in Apocynaceae family [6] [7] [8] , one new monoterpenoid indole alkaloid, ervachinine E (1), and five known alkaloids rutaecarpine (2) [9] , 1-methyl-2-nonyl-4(1H)-quinolone (3) [10] , dihydroevocarpine (4) [11] , evocarpine (5) [11] , and 1-methyl-2-[(Z)-6-undecenyl]-4(1H)-quinolone (6) [10] were isolated and identified from the whole plants of Eravatamia chinensis. The present paper described their isolation and structural elucidation. carbon signals due to two methyl, five methylene, eight methine, and five quaternary carbons. The presence of the methine signals (G C 185.0, G H 9.94, 1H, s) revealed that the conjugated carbonyl observed in the IR spectra is due to an aldehyde function. . Detailed comparison of the NMR data of 1 with those of lirofoline A [12] suggested that their structures were closely related, except for the pattern of substitution of methoxy group. The presence of a methine signal (G C 94.7, G H 6.94, br d, J = 2.4) in 1 implied that the methoxy group was located at C-11 (G C 158.7) (Fig. 2) , which was further line A [12] .
Results and Discussion
The relative configuration of 1 established from the ROESY spectrum (Fig. 3) and coupling constant was consistent with that of lirofoline A [12] . Thus, it allowed the assignment of compound 1 to be ervachinine E, a new monoterpenoid indole alkaloid of the rearranged ibogan type.
Experimental

General experimental procedures
Optical rotations were measured on a JASCO P-1020 
Extraction and isolation
The powder of E. chinensis (7.5 kg) was extracted three times with 95% EtOH. The extract was concentrated under reduced pressure, followed by partitioning between EtOAc and 3% tartaric acid. The aqueous phase was adjusted to pH 9-10 with saturated Na 2 CO 3 and extracted with CHCl 3 to give crude alkaloids (40.0 g). The crude alkaloids were subjected to a Si gel column (petroleum ether-Me 2 CO, 1 : 0 ĺ 0 : 1) to obtain four major fractions A-D. Fraction A (3.5 g) was subjected to silica gel CC eluted with petroleum ether-Me 2 CO-Et 2 NH (30 : 1 : 0.1o15 : 1 : 0.1) to give 3 (20.0 mg), 4 (2.9 mg), 5 (68.2 mg), and 6 (6.6 mg). Fraction D was further chromatographed over a Si gel (300-400 mesh) column (petroleum ether-Me 2 CO-Et 2 NH, 10 : 1 : 0.2 ĺ 4 : 1 : 0.2) followed by Sephadex LH-20 CC eluted with CH 3 OH to afford 1 (3.7 mg), and 2 (2.4 mg). 
Cytotoxicity assay
Five human cancer cell lines, human myeloid leukemia HL-60, hepatocellular carcinoma SMMC-7721, lung cancer A-549, breast cancer MCF-7, and colon cancer SW480 cells, were used in the cytotoxic assay. All the cells were cultured in RPMI-1640 or DMEM medium (Hyclone, USA), supplemented with 10% fetal bovine serum (Hyclone, USA) in 5% CO 2 at 37 °C. The cytotoxicity assay was performed according to the MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) method in 96-well micro-plates. BrieÀy, 100 μL of adherent cells was seeded into each well of 96-well cell culture plates [13] and allowed to adhere for 12 h before drug addition, while suspended cells were seeded just before drug addition with an initial density of 1 × 10 5 cells/mL. Each tumor cell line was exposed to the test compound dissolved in DMSO at concentrations of 0.062 5, 0.32, 1.6, 8, and 40 μmol in triplicates for 48 h, with cisplatin (Sigma, USA) as positive controls. After compound treatment, cell viability was detected and a cell growth curve was graphed. IC 50 were calculated by Reed and Muench's method [14] . 
